Clinical Trials Browser

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

NCT07211048 2026-01-21

Anti CD19 Gene Therapy for B-cell Lymphoma

Phase NA Recruiting

18 enrolled

Lymphoid

Lymphoma, B-Cell

NCT07345741 2026-01-16

Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Phase NA Not yet recruiting

28 enrolled

Lymphoid

Recurrence, Lymphoma, B-Cell

NCT06744075 2025-12-30

CELERITY

Phase NA Active not recruiting

108 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, B-Cell, Neoplasm, Residual

NCT06004167 2025-12-09

Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)

Phase NA Completed

10 enrolled

Lymphoid

Lymphoma, Lymphoma, Follicular, Recurrence, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05556239 2025-12-08

STAY-STRONG

Phase NA Completed

42 enrolled

Lymphoid

Hodgkin Disease, Motor Activity, Lymphoma, B-Cell, Sarcopenia

NCT06485076 2025-12-03

EPC-MM+L

Phase NA Recruiting

144 enrolled

LymphoidPlasma cell

Multiple Myeloma, Lymphoma, B-Cell

NCT06508775 2025-11-26

LONGSAFE

Phase NA Recruiting

40 enrolled

DermatologicLymphoidOther hematologic neoplasm

Melanoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05940272 2025-10-09

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

Phase NA Recruiting

48 enrolled

LymphoidSarcoma

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT06961669 2025-05-29

ECAR01

Phase NA Recruiting

18 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Recurrence, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

Anti CD19 Gene Therapy for B-cell Lymphoma

Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

CELERITY

Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)

STAY-STRONG

EPC-MM+L

LONGSAFE

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

ECAR01